Rate My Professor Carl Kirkpatrick

Professor Carl Kirkpatrick is Professor of Pharmacy Practice in the Faculty of Pharmacy and Pharmaceutical Sciences at Monash University. He earned a Bachelor of Pharmacy (Honours) and a PhD from the University of Otago, New Zealand, in the area of aminoglycoside pharmacokinetics and pharmacodynamics. Before entering academia, he worked as a clinical pharmacist in intensive care and clinical pharmacology. He joined Monash University in 2011 as Head of the Department of Pharmacy Practice and co-Director of the Centre for Medicine Use and Safety (CMUS), subsequently serving as Director of CMUS and Director of Pharmacy Education from 2011 to 2019. He is now based at the Monash Institute of Pharmaceutical Sciences and serves as Director of the Monash–Moderna Quantitative Pharmacology Accelerator.

Professor Kirkpatrick's research centers on population pharmacokinetic and pharmacodynamic modelling to optimize pharmacotherapy, with a focus on antibacterial agents, dosing in renal dysfunction, obesity, drugs in breast milk, quality use of medicines, pharmacogenomics, anti-infectives, and mRNA therapeutics. His work has an h-index of 56 and over 12,416 citations. Key publications include 'Monte Carlo simulations: Maximizing antibiotic pharmacokinetic/pharmacodynamic target attainment using a population pharmacokinetic model of piperacillin and tazobactam in critically ill patients' (2011), 'Population pharmacokinetics and pharmacodynamics of cefpirome in critically ill patients' (2007), 'AI for NONMEM Coding in Pharmacometrics Research and Education: Shortcut or Pitfall?' (2025), and 'Clinical and Quantitative Pharmacology Considerations of mRNA Therapeutics and Vaccine Development: Bridging Translational and Platform Gaps for Enhanced Decision Making' (2025). He has supervised more than 22 PhD students, obtained continuous NHMRC funding, and held leadership positions such as President of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), Chair of the World Congress of Basic and Clinical Pharmacology 2026, and member of the Advisory Committee on Prescription Medicines Pharmaceutical Subcommittee. His awards include the 2025 ASCEPT Fellowship, 2024 Fellowship of the British Pharmacological Society, and 2024 Australian Award for University Teaching.